Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
Product deliveries scheduled in Q3 of 2023
Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Affordability is key to providing accessible healthcare for Bharat.
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Subscribe To Our Newsletter & Stay Updated
